Analyst Ranking
Top 41%
#2256 out of 5510 analysts
Average Return
+1.71%
Win Rate
56%10 out of 18
Risk vs Reward
Poor
Good

Ryan Halsted's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iqvia Holdings IncIQV
+52.72%$173.96$265.67
2026-03-03 -
2026-09-14
Buy
Medpace Holdings IncMEDP
+45.03%$410.54$595.41
2026-04-24 -
2026-09-14
Buy
Medpace Holdings IncMEDP
+27.94%$465.38$595.41
2026-03-03 -
2026-09-14
Buy
Healthequity IncHQY
+12.71%$85.21$96.04
2026-06-03 -
2026-09-14
Buy
Healthequity IncHQY
+9.15%$87.99$96.04
2026-05-29 -
2026-09-14
Buy

Ryan Halsted Analyst Color

Get additional color on Ryan Halsted's coverage of popular stocks

Ryan Halsted's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mckesson CorpMCK
2Hold$845.00-7.24%Reiterates
2 days ago
Cencora IncCOR
2Hold$330.00+1.16%Reiterates
8 days ago
Phreesia IncPHR
1Buy$19.00+82.34%Reiterates
13 days ago
Waystar Holding CorpWAY
1Buy$44.00+76.71%Reiterates
20 days ago
Cardinal Health IncCAH
1Buy$276.00+17.50%Initiates Coverage On
a month ago
Medline IncMDLN
3Buy$46.00+41.15%Maintains
a month ago
Charles River Laboratories International IncCRL
1Buy$282.00+3.26%Maintains
a month ago
Iqvia Holdings IncIQV
2Buy$247.00-7.03%Maintains
2 months ago
Medpace Holdings IncMEDP
3Buy$692.00+16.22%Maintains
2 months ago
Icon PLCICLR
3Buy$185.00+9.51%Upgrades
3 months ago
Healthequity IncHQY
2Buy$108.00+12.45%Reiterates
3 months ago
Healthcare Services Group IncHCSG
2Hold$24.00+8.89%Maintains
5 months ago
Doximity IncDOCS
1Buy$44.00+66.73%Reiterates
6 months ago
Evolent Health IncEVH
1Hold$3.00-26.83%Maintains
7 months ago
Privia Health Group IncPRVA
1Buy$31.00+48.47%Reinstates
8 months ago
Trubridge IncTBRG
1Hold$23.00-12.35%Reinstates
8 months ago
Ensign Group IncENSG
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.